Mospd2tm1.1Geno
Targeted Allele Detail
|
|
| Symbol: |
Mospd2tm1.1Geno |
| Name: |
motile sperm domain containing 2; targeted mutation 1.1, Genoway |
| MGI ID: |
MGI:6690852 |
| Gene: |
Mospd2 Location: ChrX:163719165-163763371 bp, - strand Genetic Position: ChrX, 76.75 cM, cytoband F5
|
| Alliance: |
Mospd2tm1.1Geno page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:301755
|
| Parent Cell Line: |
Not Specified (ES Cell)
|
| Strain of Origin: |
Not Specified
|
|
| Allele Type: |
|
Targeted (Conditional ready) |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: A loxP site and FRT-flanked neomycin selection cassette were inserted upstream of exon 4 and a loxP site was inserted downstream of exon 5 via homologous recombination. The FRT-flanked neomycin selection cassette was deleted via FLP1-mediated recombination in the germline.
(J:301755)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Mospd2 Mutation: |
13 strains or lines available
|
|
| Original: |
J:301755 Yacov N, et al., MOSPD2 is a therapeutic target for the treatment of CNS inflammation. Clin Exp Immunol. 2020 Aug;201(2):105-120 |
| All: |
1 reference(s) |
|